Rollins Financial’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rollins Financial's LLY Position: Q4 2023 in Review
Rollins Financial reduced its Eli Lilly (LLY) stake by 36% in Q4 2023, selling an estimated $257K and leaving 782 shares worth $456K. The position accounts for 0.1% of the portfolio, ranked #71.
Rollins Financial first reported a position in LLY in Q4 2022 and has held it in 4 quarters since. The position peaked at $657K in Q3 2023. 3,276 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- Rollins Financial held 782 shares of Eli Lilly worth $456K as of Q4 2023.
- Rollins Financial sold 441 Eli Lilly shares in Q4 2023, an estimated $257K.
- Eli Lilly made up 0.1% of Rollins Financial's portfolio in Q4 2023, its #71 holding.
- Rollins Financial first reported a position in Eli Lilly in Q4 2022 and has held it in 4 quarters since.
- Rollins Financial's Eli Lilly position peaked at $657K in Q3 2023.
- 3,276 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on Rollins Financial's 13F filing for Q4 2023, filed 6 Feb 2024.